Fulcrum Asset Management LLP Cuts Stock Position in Cigna Group $CI

Fulcrum Asset Management LLP trimmed its holdings in Cigna Group (NYSE:CI) by 30.1% during the 3rd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 7,707 shares of the health services provider’s stock after selling 3,319 shares during the period. Fulcrum Asset Management LLP’s holdings in Cigna Group were worth $2,222,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other hedge funds have also recently made changes to their positions in CI. Harbor Capital Advisors Inc. grew its position in shares of Cigna Group by 119.5% during the third quarter. Harbor Capital Advisors Inc. now owns 90 shares of the health services provider’s stock worth $26,000 after purchasing an additional 49 shares in the last quarter. Collier Financial purchased a new position in Cigna Group in the 3rd quarter worth approximately $34,000. Founders Capital Management boosted its stake in Cigna Group by 53.0% in the 3rd quarter. Founders Capital Management now owns 153 shares of the health services provider’s stock worth $44,000 after purchasing an additional 53 shares during the period. Traub Capital Management LLC bought a new position in Cigna Group in the 2nd quarter worth approximately $48,000. Finally, Twin Peaks Wealth Advisors LLC purchased a new stake in Cigna Group during the 2nd quarter valued at approximately $52,000. Institutional investors own 86.99% of the company’s stock.

Insider Buying and Selling

In other news, insider Everett Neville sold 1,719 shares of the business’s stock in a transaction that occurred on Monday, March 2nd. The stock was sold at an average price of $288.91, for a total transaction of $496,636.29. Following the transaction, the insider owned 5,670 shares of the company’s stock, valued at approximately $1,638,119.70. The trade was a 23.26% decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, insider Nicole S. Jones sold 2,307 shares of the stock in a transaction on Monday, March 2nd. The shares were sold at an average price of $288.91, for a total value of $666,515.37. Following the sale, the insider owned 32,647 shares in the company, valued at $9,432,044.77. The trade was a 6.60% decrease in their position. The disclosure for this sale is available in the SEC filing. Corporate insiders own 0.70% of the company’s stock.

Analyst Upgrades and Downgrades

Several research firms have recently issued reports on CI. UBS Group reiterated a “buy” rating and set a $375.00 price objective on shares of Cigna Group in a research report on Monday, February 9th. Sanford C. Bernstein raised shares of Cigna Group from a “market perform” rating to an “outperform” rating and raised their target price for the company from $307.00 to $358.00 in a research note on Thursday, March 12th. Robert W. Baird reduced their price target on shares of Cigna Group from $372.00 to $315.00 and set an “outperform” rating on the stock in a report on Thursday, December 11th. Deutsche Bank Aktiengesellschaft boosted their price target on shares of Cigna Group from $301.00 to $304.00 and gave the stock a “buy” rating in a research note on Tuesday, February 10th. Finally, Guggenheim reissued a “buy” rating and set a $318.00 price objective on shares of Cigna Group in a report on Monday, February 2nd. One equities research analyst has rated the stock with a Strong Buy rating, seventeen have issued a Buy rating and four have given a Hold rating to the stock. Based on data from MarketBeat, Cigna Group currently has an average rating of “Moderate Buy” and an average target price of $333.11.

Cigna Group Price Performance

CI stock opened at $264.87 on Thursday. Cigna Group has a 52 week low of $239.51 and a 52 week high of $350.00. The firm has a market capitalization of $69.80 billion, a P/E ratio of 11.94, a price-to-earnings-growth ratio of 0.91 and a beta of 0.27. The company has a fifty day simple moving average of $278.57 and a two-hundred day simple moving average of $282.09. The company has a quick ratio of 0.74, a current ratio of 0.74 and a debt-to-equity ratio of 0.74.

Cigna Group (NYSE:CI) last posted its earnings results on Thursday, February 5th. The health services provider reported $8.08 earnings per share for the quarter, topping analysts’ consensus estimates of $7.88 by $0.20. The firm had revenue of $72.50 billion for the quarter, compared to the consensus estimate of $69.53 billion. Cigna Group had a net margin of 2.17% and a return on equity of 19.46%. The business’s quarterly revenue was up 10.4% on a year-over-year basis. During the same period in the previous year, the firm posted $6.64 EPS. Cigna Group has set its FY 2026 guidance at 30.250- EPS. Analysts anticipate that Cigna Group will post 29.77 earnings per share for the current fiscal year.

Cigna Group Increases Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Thursday, March 19th. Shareholders of record on Thursday, March 5th will be given a dividend of $1.56 per share. This represents a $6.24 dividend on an annualized basis and a yield of 2.4%. This is a boost from Cigna Group’s previous quarterly dividend of $1.51. The ex-dividend date is Thursday, March 5th. Cigna Group’s dividend payout ratio (DPR) is currently 28.13%.

About Cigna Group

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.